ILXQuant Biodefense and Pandemic Preparedness Basket Index

Fixed-basket index of 10 companies providing the infrastructure of biological security -- next-generation vaccine platforms (Novavax protein subunit, Vaxart oral), US strategic national stockpile vaccines (Emergent BioSolutions), biodefense antivirals (SIGA Technologies -- the only FDA-approved smallpox antiviral), molecular diagnostics (Qiagen), immune surveillance sequencing (Adaptive Biotechnologies), food and environmental biosurveillance (Neogen), veterinary outbreak detection (Heska -- critical for H5N1 zoonotic monitoring), synthetic biology for biodefense (Precigen), and drug delivery innovation (Nektar). Government biodefense contracts provide recession-proof revenue streams. Rebalances quarterly to equal weight.

Index identifier
ILXBIO
Category
Basket
Universe
Fixed basket -- 10 biodefense and pandemic preparedness companies (equal weight)
Currency
USD
Inception
2020-03-02
Rebalancing
Quarterly (first Monday of March, June, September, December)
Index fee
0.60% p.a.
Reference benchmark
iShares Aero and Defense (ITA)

Performance and risk

All figures below are measured over a trailing window of up to 1,260 trading days (approximately five years), not since index inception.

Performance and risk — 2021-10-13 to 2026-08-13
Annualised return-7.30%
Sharpe ratio-0.17
Calmar ratio-0.09
Volatility42.68%
Maximum drawdown-78.05%
Return, 1 month+5.10%
Return, 3 months+7.63%
Return, 1 year+43.81%
Return, year to date+10.84%

Full performance history, drawdown analysis, rolling risk metrics and portfolio breakdowns for this index are available in the ILX Quant platform.